BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8480819)

  • 1. Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease.
    Yesavage JA; Brooks JO; Taylor J; Tinklenberg J
    Am J Psychiatry; 1993 May; 150(5):742-7. PubMed ID: 8480819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-object test: a new brief clinical assessment for aphasia-apraxia-agnosia.
    Still CN; Goldschmidt TJ; Mallin R
    South Med J; 1983 Jan; 76(1):52-4. PubMed ID: 6823578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aphasia, apraxia, and agnosia in the diagnosis of dementia.
    Kramer JH; Duffy JM
    Dementia; 1996; 7(1):23-6. PubMed ID: 8788078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantified neuropsychological study in senile dementia of Alzheimer's type].
    Roudier M; Marcie P; Podrabinek N; Lamour Y; Davous P
    Encephale; 1989; 15(4):397-403. PubMed ID: 2806182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tests for aphasia, apraxia and agnosia].
    Hasegawa T; Tanemura J
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():318-21. PubMed ID: 9097612
    [No Abstract]   [Full Text] [Related]  

  • 6. Slowly progressive visual agnosia or apraxia without dementia.
    De Renzi E
    Cortex; 1986 Mar; 22(1):171-80. PubMed ID: 2423295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment of Alzheimer disease.
    Folstein MF; Whitehouse PJ
    Neurobehav Toxicol Teratol; 1983; 5(6):631-4. PubMed ID: 6366602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tests for aphasia, apraxia, and agnosia].
    Hasegawa T; Kashiwagi T
    Nihon Rinsho; 1979 Jun; Suppl():1824-7. PubMed ID: 90746
    [No Abstract]   [Full Text] [Related]  

  • 9. The concept of subcortical dementia.
    Huber SJ; Paulson GW
    Am J Psychiatry; 1985 Nov; 142(11):1312-7. PubMed ID: 2932922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Analysis of Mini Mental State Examination Pentagon in Vascular Dementia and Alzheimer's Disease: A Longitudinal Explorative Study.
    Lo Buono V; Bonanno L; Corallo F; Foti M; Palmeri R; Marra A; Di Lorenzo G; Todaro A; Bramanti P; Bramanti A; Marino S
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1666-1672. PubMed ID: 29503167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal symptoms with special reference to screening tests and causative factors of aphasia, apraxia and agnosia].
    Shida K
    Nihon Rinsho; 1969 Sep; 27(9):2203-8. PubMed ID: 5389202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Verbal ability of Alzheimer's disease patients and very elderly control patients using the Aachen aphasia test].
    Ecklin R; Schönenberger PM
    Schweiz Arch Neurol Psychiatr (1985); 1992; 143(4):371-9. PubMed ID: 1279795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Whitwell JL; Weigand SD; Duffy JR; Clark HM; Strand EA; Machulda MM; Spychalla AJ; Senjem ML; Jack CR; Josephs KA
    Neurology; 2017 Nov; 89(22):2271-2279. PubMed ID: 29093069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease presenting as slowly progressive aphasia and slowly progressive visual agnosia: two early reports.
    Pantel J
    Arch Neurol; 1995 Jan; 52(1):10. PubMed ID: 7826265
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cognitive manifestations of Alzheimer's disease].
    Ousset PJ
    Rev Prat; 1998 Nov; 48(17):1891-7. PubMed ID: 9854391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.